Details of the Drug Reposition

General Information of This Drug (ID: DM3YZCV)

Drug Name
ICAR30 T cells   DM3YZCV
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Anaplastic large cell lymphoma DISP4D1R 2A90.A Phase 1 [1]
Hodgkin lymphoma DISX2OUL 2B30 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03383965) CD30 Targeted CAR-T in Treating CD30-Expressing Lymphomas